What is EEG Biofeedback CT?
EEG Biofeedback CT specializes in advanced neurotherapy, offering corrective care for individuals of all ages experiencing symptoms and disorders such as ADHD, anxiety, and executive function struggles. The company leverages neurofeedback and other treatment modalities to provide targeted therapeutic interventions. This strategic investment will likely fuel the scaling of their innovative treatment solutions and market reach.
How much funding has EEG Biofeedback CT raised?
EEG Biofeedback CT has raised a total of $46K across 1 funding round:
Debt
$46K
Debt (2021): $46K with participation from PPP
What's next for EEG Biofeedback CT?
With substantial expansion capital at the significant Series B/C stage, EEG Biofeedback CT is poised for a period of rapid development and market penetration. The company is expected to enhance its service offerings, potentially expand its geographical footprint, and further invest in research and development to refine its neurofeedback technologies. This financing underscores investor confidence in EEG Biofeedback CT's potential to address a growing demand for effective neurotherapy solutions.
See full EEG Biofeedback CT company page